GAO: Oversight of imported radiological material needs to be improved

On Jan. 12, the U.S. Government Accounting Office (GAO) published a 28-page report on its website that called for U.S. Customs and Border Protection (CBP) to improve its ability to verify the licenses of imported radiological material.

“GAO recommends that CBP develop a monitoring system to help ensure that CBP officials comply with the agency’s license verification policy, conduct an assessment to determine relevant information that is not included in the automated alerts, and develop a system that allows it to identify shipments of greatest risk,” according to the GAO report.

The U.S. Nuclear Regulatory Commission regulates the possession and import of such materials, though the CPB is required to verify shipments entering the U.S. The newly released report examined the CPB’s policies and the effectiveness of these policies.

The GAO had three recommendations:

  1. CBP should develop a monitoring system to help ensure that CBP officials comply with license verification policies and procedures.
  2. CBP should conduct a comprehensive assessment of information not included in the automated alert to determine what information is needed to identify licensable radiological material.
  3. CBP should develop a system that better identifies shipments of radiological material that pose the greatest risk and revise CBP’s policies and procedures as necessary to verify licenses for these shipments.
""
Nicholas Leider, Managing Editor

Nicholas joined TriMed in 2016 as the managing editor of the Chicago office. After receiving his master’s from Roosevelt University, he worked in various writing/editing roles for magazines ranging in topic from billiards to metallurgy. Currently on Chicago’s north side, Nicholas keeps busy by running, reading and talking to his two cats.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup